Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.
Dr. Kirby is a dermatologist and clinician-researcher at Penn State Hershey. She earned her Medical degree from the University of Virginia, then completed her Dermatology Residency at the University of Pennsylvania. In her clinical and research work, she is interested in acneiform conditions including acne, rosacea, and, especially, hidradenitis suppurativa – its effects on people, outcome measurement, and pathomechanisms. She is the PI of a number of clinical research trials. All of this is made possible by the support of her husband and two daughters.
How to recognize HS, especially when it's early (or when it's a good day!). The pathophysiology of HS has been somewhat controversial over the past several decades. What components of the immune system are involved? What structures of the skin are involved? We'll give you the latest insights into these questions and how to help your patients understand it!
Hidradenitis Suppurativa (HS) is a chronic, immune-mediated skin disease. Despite scientific advancements, HS can be a challenge to manage. HS expert panelists examine current approaches to managing HS and share their top tips and tricks to achieve optimal outcomes.
Hidradenitis Suppurativa (HS) can be a roller coaster. It’s a chronic disease with intermittent flares. Patients with HS can benefit from medicines, procedures, referrals to other practitioners, and more. In this panel discussion, HS experts help you create a treatment plan for your patients using all the tools we have at our fingertips!
Description: This session will review the clinical presentation and severity grading of HS. The decision between topical and systemic therapies will be reviewed and the clinical evidence for TNF, JAK, and IL-17/23 inhibition will be discussed.
Review different treatment options for a patient with hidradenitis suppurativa experiencing severe pain.
Surgery is a critical aspect of HS management often necessary to achieve maximal improvement in disease activity. This course will provide practical guidance for when to consider surgery and how to perform surgical procedures for HS in the outpatient clinic.
A variety of clinical guidelines have recently been developed for the treatment of Hidradenitis Suppurativa. These guidelines appreciate the complexity of disease as well as a number of gaps in our knowledge regarding disease pathogenesis, disease heterogeneity, and predicting response to therapy.
The aim of this course is to educate practitioners on the best way to have efficient and effective patient encounters. This includes building rapport at the initial consult and setting patient expectations with regards to treatment responses, types of treatment that may be necessary, and long term goals. Emphasis will be placed on providing focused and critical education for patients regarding their disease. Approaches for management of acute flares will also be covered.
